Infectious Diseases (except HIV/AIDS)

  1. Ammonium Sulfate Addition Reduces the Need for Guanidinium Isothiocyanate in the Denaturing Transport Medium Used for SARS-COV-2 RNA Detection

    1. Ge Liu
    2. Jiaoyan Jia
    3. Jianfeng Zhong
    4. Hanfang Jiang
    5. Yongqi Yang
    6. Xiujing Lu
    7. Zhendan He
    8. Qinchang Zhu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Longitudinal monitoring of SARS-CoV-2 neutralizing antibody titers and its impact on employee personal wellness decisions

    1. Rianna Vandergaast
    2. Timothy Carey
    3. Lukkana Suksanpaisan
    4. Chase Lathrum
    5. Riya Narjari
    6. Michelle Haselton
    7. Luke Schnebeck
    8. Aroshi Wijesekara
    9. Andrew Duncan
    10. Luke Russell
    11. Shruthi Naik
    12. Kah-Whye Peng
    13. Patrycja Lech
    14. Stephen J. Russell

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern

    1. Maggie Li
    2. Evan J. Beck
    3. Oliver Laeyendecker
    4. Yolanda Eby
    5. Aaron A. R. Tobian
    6. Patrizio Caturegli
    7. Camille Wouters
    8. Gregory R. Chiklis
    9. William Block
    10. Robert O. McKie
    11. Michael J. Joyner
    12. Timothy D. Wiltshire
    13. Allan B. Dietz
    14. Thomas J. Gniadek
    15. Arell J. Shapiro
    16. Anusha Yarava
    17. Karen Lane
    18. Daniel F. Hanley
    19. Evan M. Bloch
    20. Shmuel Shoham
    21. Edward R. Cachay
    22. Barry R. Meisenberg
    23. Moises A. Huaman
    24. Yuriko Fukuta
    25. Bela Patel
    26. Sonya L. Heath
    27. Adam C. Levine
    28. James H. Paxton
    29. Shweta Anjan
    30. Jonathan M. Gerber
    31. Kelly A. Gebo
    32. Arturo Casadevall
    33. Andrew Pekosz
    34. David J. Sullivan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Viral cultures, Polymerase Chain Reaction Cycle Threshold Values and Viral Load Estimation for SARS-CoV-2 Infectious Potential Assessment in Hematopoietic Stem Cell and Solid Organ Transplant Patients: A Systematic Review

    1. Tom Jefferson
    2. Elizabeth A. Spencer
    3. John M. Conly
    4. Elena C. Rosca
    5. Susanna Maltoni
    6. Jon Brassey
    7. Igho J. Onakpoya
    8. David H. Evans
    9. Carl J. Heneghan
    10. Annette Plüddemann

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Comparison of Rapid Antigen Tests' Performance Between Delta and Omicron Variants of SARS-CoV-2

    1. Apurv Soni
    2. Carly Herbert
    3. Andreas Filippaios
    4. John Broach
    5. Andres Colubri
    6. Nisha Fahey
    7. Kelsey Woods
    8. Janvi Nanavati
    9. Colton Wright
    10. Taylor Orwig
    11. Karen Gilliam
    12. Vik Kheterpal
    13. Thejas Suvarna
    14. Chris Nowak
    15. Summer Schrader
    16. Honghuang Lin
    17. Laurel O’Connor
    18. Caitlin Pretz
    19. Didem Ayturk
    20. Elizabeth Orvek
    21. Julie Flahive
    22. Peter Lazar
    23. Qiming Shi
    24. Chad Achenbach
    25. Robert Murphy
    26. Matthew Robinson
    27. Laura Gibson
    28. Pamela Stamegna
    29. Nathaniel Hafer
    30. Katherine Luzuriaga
    31. Bruce Barton
    32. William Heetderks
    33. Yukari C. Manabe
    34. David McManus

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Assessment of potential risk factors for COVID-19 among health care workers in a health care setting in Delhi, India -a cohort study

    1. Mridu Dudeja
    2. Aqsa Shaikh
    3. Farzana Islam
    4. Yasir Alvi
    5. Mohammad Ahmad
    6. Varun Kashyap
    7. Vishal Singh
    8. Anisur Rahman
    9. Meely Panda
    10. Neetu Shree
    11. Shyamasree Nandy
    12. Vineet Jain

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. An Immunobridging Study to Evaluate the Neutralizing Antibody Titer in Adults Immunized with Two Doses of Either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901

    1. Josue Antonio Estrada
    2. Chien-Yu Cheng
    3. Shin-Yen Ku
    4. Hui-Chun Hu
    5. Hsiu-Wen Yeh
    6. Yi-Chun Lin
    7. Cheng-Pin Chen
    8. Shu-Hsing Cheng
    9. Robert Janssen
    10. I-Feng Lin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review

    1. Jennifer Pillay
    2. Lindsay Gaudet
    3. Aireen Wingert
    4. Liza Bialy
    5. Andrew S Mackie
    6. D Ian Paterson
    7. Lisa Hartling

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  9. Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial

    1. Pengfei Jin
    2. Xiling Guo
    3. Wei Chen
    4. Shihua Ma
    5. Hongxing Pan
    6. Lianpan Dai
    7. Pan Du
    8. Lili Wang
    9. Lairun Jin
    10. Yin Chen
    11. Fengjuan Shi
    12. Jingxian Liu
    13. Xiaoyu Xu
    14. Yanan Zhang
    15. George F. Gao
    16. Cancan Chen
    17. Jialu Feng
    18. Jingxin Li
    19. Fengcai Zhu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Duration of Protection Against SARS-CoV-2 Reinfection and Associated Risk of Reinfection Assessed with Real-World Data

    1. Shannon L. Reynolds
    2. Harvey W. Kaufman
    3. William A. Meyer
    4. Chris Bush
    5. Oren Cohen
    6. Kathy Cronin
    7. Carly Kabelac
    8. Sandy Leonard
    9. Steve Anderson
    10. Valentina Petkov
    11. Douglas Lowy
    12. Norman Sharpless
    13. Lynne Penberthy

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 193 of 716 Next